首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 93 毫秒
1.
重组蛋白质的过表达常导致其在胞内发生错误折叠和聚集,形成被称为包含体的聚集体。因此,蛋白质复性是许多基因重组蛋白质药物生产过程的重要步骤。本文简要介绍包含体提取、纯化和溶解工艺,重点阐述蛋白质复性技术,包括稀释复性、稀释添加剂、人工分子伴侣、柱色谱复性和反胶团溶解复性等。最后展望蛋白质复性技术的发展和应用,特别是荷电介质对同电荷蛋白质复性的促进作用。  相似文献   

2.
包含体的体外复性研究进展   总被引:3,自引:0,他引:3  
黄泓  张伟 《生命的化学》2003,23(5):397-400
在大肠杆菌中大量表达的重组蛋白质常常形成无活性的、不溶性的包含体。包含体经过液固分离、洗涤、变性溶解后,经过一个合理的复性过程可重新折叠成有活性的蛋白质。本文概述了常用的包含体复性方法,并对近年来出现的色谱复性法和应用一些低分子量添加剂等来提高蛋白质复性的产率做了简述。  相似文献   

3.
包涵体蛋白体外复性的研究进展   总被引:39,自引:1,他引:38  
方敏  黄华樑   《生物工程学报》2001,17(6):608-612
外源基因在大肠杆菌中高水平表达时 ,通常会形成无活性的蛋白聚集体即包涵体。包涵体富含表达的重组蛋白 ,经分离、变性溶解后须再经过一个合适的复性过程实现变性蛋白的重折叠 ,才能够得到生物活性蛋白。近年来 ,发展了许多特异的策略和方法来从包涵体中复性重组蛋白。最近的进展包括固定化复性以及用一些低分子量的添加剂等来减少复性过程中蛋白质的聚集 ,提高活性蛋白的产率。  相似文献   

4.
重组蛋白包涵体的复性研究   总被引:21,自引:0,他引:21  
重组蛋白在大肠杆菌中的高表达往往形成不可溶、无生物活性的包涵体,需经过变性溶解后,在适当条件下复性形成天然的构象,才可恢复其生物活性.变复性实验是建立在对蛋白质体外折叠机制的了解的基础上.根据近年来对蛋白质折叠机制的认识和重组蛋白包涵体在复性方面的主要进展,论述以下3个方面的内容:1)蛋白质在细胞内的折叠机制;2)蛋白质体外折叠机制;3)蛋白质复性的策略和方法.  相似文献   

5.
包含体内重组蛋白质的复性   总被引:2,自引:0,他引:2  
具有临床、工业生产、药用功能的真核生物蛋白质的供给常常受到其天然来源的限制。可喜的是基因工程技术的发展使许多真核生物蛋白质能在细菌细胞中进行表达[1] 。大肠杆菌由于培养和基因操作容易而成为最受欢迎的表达系统 ,但是重组蛋白质在大肠杆菌中的高水平表达常常导致以包含体形式存在的胞內聚集的变性蛋白质的形成。这种变性蛋白质的量可高达总的重组蛋白质量的95%。由于以包含体形式存在的聚集蛋白质分子不具有正确的三维结构 (天然结构 ) ,它们在水溶液中通常不溶解且没有活性 ,因此大肠杆菌中包含体的形成就意味着可溶性重组蛋白…  相似文献   

6.
李烈军  王捷 《生物技术》2005,15(3):85-87
外源基因在大肠杆菌中高水平表达时,通常会形成不溶性、无活性的蛋白聚集体即包含体。包含体富含表达的重组蛋白,经分离、变性溶解后须再经过一个合适的复性过程实现变性蛋白的重折叠,才能够得到生物活性蛋白。近年来,发展了许多特异的策略和方法来从包含体中复性重组蛋白。介绍稀释法、透析及分子排阻、固定化金属离子亲和层析、疏水层析复性等策略和进展;物理化学因素、前导肽协助蛋白折叠;人工分子伴侣辅助蛋白折叠及反胶束、多聚物用于蛋白复性。  相似文献   

7.
RGD-葡激酶的凝胶过滤层析法复性及其纯化   总被引:3,自引:0,他引:3  
构建的溶栓和抗栓双重功能的RGD-葡激酶突变体(RGD-Sak)在大肠杆菌中高表达,目的蛋白质以包涵体形式存在。为获得有活性的蛋白质,需要对包涵体进行变复性。利用凝胶层析方法对包涵体中RGD-Sak进行复性,并与稀释复性法进行比较,发现凝胶柱复性方法具有操作周期短、简便、成本低而高效等优点。复性后蛋白质用Q-Sepharose FF离子交换进一步纯化,纯度达95%,酪蛋白凝胶板活性测定表明两种复性法得到的蛋白质比活性相当。圆二色谱测定显示两种复性法得到的蛋白质的二级结构成份和谱形一致,说明在两种复性过程中完成了RGD-Sak分子的正确折叠。  相似文献   

8.
抗肿瘤血管三结构域单链抗体VH/L的构建与表达   总被引:2,自引:1,他引:1  
以本室研制的一株抗肿瘤血管单克隆体AA98为基础,采用PCR扩增抗体AA98基因的重链可变区(VH)和轻链(L),以重链恒定区1(CH1)5′端12个氨基酸的序列作为连接肽,并将连接肽中的Lys变为Ser,构建VH-连接肽-L三结构域单链抗体。重组VH/L单链抗体在大肠杆菌中得到了高效表达,其表达量占菌体总蛋白质的20%。,表达的蛋白质在菌内形成包含体,经凝胶过滤法复性,获得了有抗原结合活性的VH/L。该三结构域单链抗体的成功构建和复性,为重组抗体片段的研制提供了借鉴。  相似文献   

9.
付娜  王捷 《生命的化学》2007,27(5):436-439
大肠杆菌是外源蛋白质的首选表达系统,但蛋白质易被宿主细胞蛋白酶降解或聚集形成包含体。包含体与淀粉样蛋白纤维的形成过程相似,都依赖于特异性氨基酸序列的分子间相互作用。因此,淀粉样蛋白质抗聚集的方法也可用于防止细菌表达蛋白质的聚集。另外,基于序列的新型方法也能调节蛋白质聚集。  相似文献   

10.
杨涌 《生物学通报》2011,46(9):23-24
分析对细菌的3种常见误解的原因,说明细菌尽管没有内质网、高尔基体,但也能通过共转运和翻译后转运分泌蛋白质。光合细菌中光合作用的电子供体不是水,而是硫化氢等无机硫化物,因而不放出氧气。通过基因工程生产重组人干扰素,最常用的受体细胞是大肠杆菌,重组人干扰素常常会在细菌体中聚集成不溶性的包涵体,工程菌经发酵后将菌体破裂,经分离、纯化、复性,即得到高纯度、高生物活性的重组人干扰素。  相似文献   

11.
Optimized conditions are needed to refold recombinant proteins from bacterial inclusion bodies into their biologically active conformations. In this study, we found two crucial requirements for efficient refolding of cationic tetrameric chicken avidin. The first step is to eliminate nucleic acid contaminants from the bacterial inclusion body. The electrostatic interactions between the remaining nucleic acids and proteins strongly enhanced protein aggregation during the refolding process. The cysteine specific reversible S-cationization procedure was successfully employed for large-scale preparation of nucleic acid free denatured protein without purification tag system. The second step is the intramolecular disulfide formation prior to refolding in dialysis removing denaturant. Disulfide intact monomeric avidin showed efficient formation of biologically active tetrameric conformation during the refolding process. Using this optimized refolding procedure, highly cationic avidin derivative designed as an intracellular delivery carrier of biotinylated protein was successfully prepared.  相似文献   

12.
Arginine is one of the universal reagents that are effective in assisting refolding of recombinant proteins from inclusion bodies. The mechanism of the effects of arginine on refolding has remained, however, to be elucidated. Here we show that arginine does not stabilize proteins against heat treatment, as demonstrated by little change in melting temperature. It does increase reversibility of thermal melting and reduce aggregation under thermal stress. The observations suggest that arginine may not facilitate refolding, but may suppress aggregation of the proteins during refolding.  相似文献   

13.
Yang Z  Zhang L  Zhang Y  Zhang T  Feng Y  Lu X  Lan W  Wang J  Wu H  Cao C  Wang X 《PloS one》2011,6(7):e22981
The production of recombinant proteins in a large scale is important for protein functional and structural studies, particularly by using Escherichia coli over-expression systems; however, approximate 70% of recombinant proteins are over-expressed as insoluble inclusion bodies. Here we presented an efficient method for generating soluble proteins from inclusion bodies by using two steps of denaturation and one step of refolding. We first demonstrated the advantages of this method over a conventional procedure with one denaturation step and one refolding step using three proteins with different folding properties. The refolded proteins were found to be active using in vitro tests and a bioassay. We then tested the general applicability of this method by analyzing 88 proteins from human and other organisms, all of which were expressed as inclusion bodies. We found that about 76% of these proteins were refolded with an average of >75% yield of soluble proteins. This "two-step-denaturing and refolding" (2DR) method is simple, highly efficient and generally applicable; it can be utilized to obtain active recombinant proteins for both basic research and industrial purposes.  相似文献   

14.
The biotechnological production of recombinant proteins is challenged by processes that decrease the yield, such as protease action, aggregation, or misfolding. Today, the variation of strains and vector systems or the modulation of inducible promoter activities is commonly used to optimize expression systems. Alternatively, aggregation to inclusion bodies may be a desired starting point for protein isolation and refolding. The discovery of the twin-arginine translocation (Tat) system for folded proteins now opens new perspectives because in most cases, the Tat machinery does not allow the passage of unfolded proteins. This feature of the Tat system can be exploited for biotechnological purposes, as expression systems may be developed that ensure a virtually complete folding of a recombinant protein before purification. This review focuses on the characteristics that make recombinant Tat systems attractive for biotechnology and discusses problems and possible solutions for an efficient translocation of folded proteins.  相似文献   

15.
包涵体蛋白的分离和色谱法体外复性纯化研究进展   总被引:2,自引:0,他引:2  
重组蛋白在大肠杆菌中表达多为无活性的包涵体形式,须经洗涤、溶解、复性后才能得到生物活性蛋白。综述了近年来包涵体蛋白分离纯化和复性技术研究进展,重点讨论了色谱法复性技术的应用,包括尺寸排阻色谱、亲和色谱、离子交换色谱、疏水相互作用色谱、固定化脂质体色谱、扩张床吸附色谱的进展情况。  相似文献   

16.
Misawa S  Kumagai I 《Biopolymers》1999,51(4):297-307
Overexpression of cloned or synthetic genes in Escherichia coli often results in the formation of insoluble protein inclusion bodies. Within the last decade, specific methods and strategies have been developed for preparing active recombinant proteins from these inclusion bodies. Usually, the inclusion bodies can be separated easily from other cell components by centrifugation, solubilized by denaturants such as guanidine hydrochloride (Gdn-HCl) or urea, and then renatured through a refolding process such as dilution or dialysis. Recent improvements in renaturation procedures have included the inhibition of aggregation during refolding by application of low molecular weight additives and matrix-bound renaturation. These methods have made it possible to obtain high yields of biologically active proteins by taking into account process parameters such as protein concentration, redox conditions, temperature, pH, and ionic strength.  相似文献   

17.
Expression of recombinant proteins in Escherichia coli often leads to formation of inclusion bodies (IB). If a recombinant protein contains one or more disulfide bonds, protein refolding and thiol oxidation reactions are required to recover its biological activity. Previous studies have demonstrated that molecular chaperones and foldases assist with the in vitro protein refolding. However, their use has been limited by the stoichiometric amount required for the refolding reaction. In search of alternatives to facilitate the use of these folding biocatalysts in this study, DsbA, DsbC, and the apical domain of GroEL (AD) were fused to the carbohydrate-binding module CBDCex of Cellulomonas fimi. The recombinant proteins were purified and immobilized in cellulose and used to assist the oxidative refolding of denatured and reduced lysozyme. The assisted refolding yields obtained with immobilized folding biocatalysts were at least twice of those obtained in the spontaneous refolding, suggesting that the AD, DsbA, and DsbC immobilized in cellulose might be useful for the oxidative refolding of recombinant proteins that are expressed as inclusion bodies. In addition, the spontaneous or assisted refolding kinetics data fitted well (r2 > 0.9) to a previously reported lysozyme refolding model. The estimated refolding (k N) and aggregation (k A) constants were consistent with the hypothesis that foldases assisted the oxidative refolding of lysozyme by decreasing protein aggregation rather than increasing the refolding rate.  相似文献   

18.
Practical considerations in refolding proteins from inclusion bodies   总被引:13,自引:0,他引:13  
Refolding of proteins from inclusion bodies is affected by several factors, including solubilization of inclusion bodies by denaturants, removal of the denaturant, and assistance of refolding by small molecule additives. We will review key parameters associated with (1) conformation of the protein solubilized from inclusion bodies, (2) change in conformation and flexibility or solubility of proteins during refolding upon reduction of denaturant concentration, and (3) the effect of small molecule additives on refolding and aggregation of the proteins.  相似文献   

19.

Background  

Escherichia coli has been most widely used for the production of valuable recombinant proteins. However, over-production of heterologous proteins in E. coli frequently leads to their misfolding and aggregation yielding inclusion bodies. Previous attempts to refold the inclusion bodies into bioactive forms usually result in poor recovery and account for the major cost in industrial production of desired proteins from recombinant E. coli. Here, we describe the successful use of the immobilized folding machineries for in vitro refolding with the examples of high yield refolding of a ribonuclease A (RNase A) and cyclohexanone monooxygenase (CHMO).  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号